The studies showed that in MS patients, miR-29b increased in memory CD4+ T cells from the peripheral blood, and miR-29b expression was repressed considerably upon T-cell activation in MS (Ponomarev et al. 2013). The gene discussed is CD4; the disease is myeloid sarcoma.